Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee

被引：2
|
作者：
Dann, Eldad J. [1 ,2 ]
Paltiel, Ora [3 ]
机构：
[1] Rambam Hlth Care Campus, Haifa, Israel
[2] Technion, Rappaport Fac Med, Haifa, Israel
[3] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 183卷 / 01期
关键词：
Hodgkin lymphoma (HL); interim PET; CT (PET-2); radiation therapy (RT); early-stage Hodgkin lymphoma (early-HL); advanced-stage Hodgkin lymphoma (advanced-HL); ADAPTED TREATMENT; TRIAL; THERAPY; INTERGROUP; ABVD; CT;
D O I：
10.1111/bjh.14905
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 133
页数：3
相关论文
共 50 条
  • [31] The prognostic value of the tumor/microenvironment signature compared to early pet scan in advanced-stage, ABVD-treated Hodgkin lymphoma patients
    Gallamini, A.
    Agostinelli, C.
    Rigacci, L.
    D'Amore, F.
    Merli, F.
    Zinzani, P.
    Vitolo, U.
    Patti, C.
    Stelitano, C.
    Di Raimondo, F.
    Levis, A.
    Trentin, L.
    Chisesi, T.
    Kamper, P.
    Pileri, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
  • [32] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE, ADVANCED-STAGE, ABVD-TREATED HODGKIN LYMPHOMA PATIENTS
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Stelitano, C.
    Feldman, T.
    Gavarotti, P.
    Sorasio, R.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S22 - S22
  • [33] FDG-PET TO GUIDE RADIOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS WITH RESIDUAL BULKY DISEASE AFTER CHEMOTHERAPY: RESULTS OF THE GHSG HD15 TRIAL
    Engert, A.
    Kobe, C.
    Markova, J.
    Haverkamp, H.
    Borchmann, P.
    Hitz, F.
    Zijlstra, J.
    Eich, H.
    Mueller, R.
    Schicha, H.
    Diehl, V.
    ANNALS OF ONCOLOGY, 2011, 22 : 96 - 96
  • [34] Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
    Girinskya, Theodore
    Ghalibafian, Mithra
    Bonniaud, Guillaume
    Baya, Aziz
    Magne, Nicolas
    Ferreira, Ivaldo
    Lumbroso, Jean
    RADIOTHERAPY AND ONCOLOGY, 2007, 85 (02) : 178 - 186
  • [35] LONG-TERM FOLLOW-UP OF SWOG S0816: RESPONSE-ADAPTED THERAPY OF ADVANCED STAGE HODGKIN LYMPHOMA USING EARLY INTERIM FDG-PET IMAGING
    Friedberg, J. W.
    Li, H.
    Schoder, H.
    Straus, D.
    Moskowitz, C.
    LeBlanc, M.
    Rimsza, L. M.
    Bartlett, N. L.
    Evens, A. M.
    Mittra, E. S.
    LaCasce, A.
    Sweetenham, J.
    Barr, P. M.
    Fanale, M. A.
    Knopp, M. V.
    Noy, A.
    Hsi, E. D.
    Cook, J. R.
    Lechowicz, M. J.
    Gascoyne, R. D.
    Leonard, J.
    Kahl, B. S.
    Cheson, B. D.
    Fisher, R. I.
    Press, O. W.
    HAEMATOLOGICA, 2016, 101 : 19 - 19
  • [36] Effect of early chemotherapy intensification with BEACOPP in high-tisk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Feldman, T.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Role of Radiotherapy after Assessment of Residual Bulky Tumor using FDG-PET in Patients with Advanced-stage Hodgkin Lymphoma: Final Report of the GHSG HD15 Trial
    Eich, H. T.
    Kobe, C.
    Dietlein, M.
    Kriz, J.
    Haverkamp, H.
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S2 - S3
  • [38] Assessment of Residual Bulky Tumor Using FDG-PET In Patients with Advanced-Stage Hodgkin Lymphoma After Completion of Chemotherapy: Final Report of the GHSG HD15 Trial
    Engert, Andreas
    Kobe, Carsten
    Markova, Jana
    Haverkamp, Heinz
    Borchmann, Peter
    Hitz, Felicitas
    Zijlstra, Josee
    Eich, Hans
    Mueller, Rolf-Peter
    Dietlein, Markus
    Diehl, Volker
    BLOOD, 2010, 116 (21) : 336 - 336
  • [39] Assessment of residual bulky tumor using FDG-PET in patients with advanced-stage Hodgkin Lymphoma after completion of chemotherapy: Final report of the GHSG HD15 trial
    Eich, H. T.
    Kobe, C.
    Kriz, J.
    Baues, C.
    Haverkamp, H.
    Fuchs, M.
    Dietlein, M.
    Engert, A.
    Mueller, R. -P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 48 - 48
  • [40] TREATMENT REDUCTION IN PATIENTS WITH ADVANCED-STAGE HODGKIN LYMPHOMA AND NEGATIVE INTERIM PET: FINAL RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 TRIAL HD18 BY THE GERMAN HODGKIN STUDY GROUP
    Borchmann, P.
    Goergen, H.
    Kobe, C.
    Fuchs, M.
    Greil, R.
    Zijlstra, J. M.
    Huettmann, A.
    Markova, J.
    Meissner, J.
    Feuring-Buske, M.
    Bentz, M.
    Dierlamm, J.
    Kuehnhardt, D.
    Lohri, A.
    Novak, U.
    Eichenauer, D.
    Eich, H.
    Baues, C.
    Stein, H.
    Diehl, V.
    Kuhnert, G.
    Dietlein, M.
    Engert, A.
    HAEMATOLOGICA, 2017, 102 : 24 - +
12345